Table 2 Characterization of different CLENs developed from breast cells
# | Nanoliposomal Preparations | Particle Size (nm) | Zeta potential (mV) |
|---|---|---|---|
1 | Doxil LP | 150 ± 2.0 | - 23 ± 0.9 |
2 | 4 T1 CLENs | 158 ± 1.9 | - 17 ± 2.5 |
3 | BT-20 CLENs | 263 ± 1.4 | - 21 ± 3.5 |
4 | SK-BR-3 CLENs | 187 ± 2.1 | − 13 ± 1.1 |
5 | CRL-2089 CLENs | 203 ± 1.9 | − 15 ± 1.3 |
6 | SK-OV-3 CLENs | 200 ± 2.2 | − 11 ± 2.3 |